Your browser doesn't support javascript.
loading
TAB2 variants cause cardiovascular heart disease, connective tissue disorder, and developmental delay.
Hanson, Jennifer; Brezavar, Daniel; Hughes, Susan; Amudhavalli, Shivarajan; Fleming, Emily; Zhou, Dihong; Alaimo, Joseph T; Bonnen, Penelope E.
Afiliação
  • Hanson J; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Brezavar D; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Hughes S; Division of Clinical Genetics, Children's Mercy Hospital, Kansas City, Missouri, USA.
  • Amudhavalli S; Division of Clinical Genetics, Children's Mercy Hospital, Kansas City, Missouri, USA.
  • Fleming E; Division of Clinical Genetics, Children's Mercy Hospital, Kansas City, Missouri, USA.
  • Zhou D; Division of Clinical Genetics, Children's Mercy Hospital, Kansas City, Missouri, USA.
  • Alaimo JT; Department of Pathology and Laboratory Medicine, Children's Mercy Hospital, Kansas City, Missouri, USA.
  • Bonnen PE; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.
Clin Genet ; 101(2): 214-220, 2022 02.
Article em En | MEDLINE | ID: mdl-34741306
Congenital heart defects (CHD) are the most commonly occurring birth defect and can occur in isolation or with additional clinical features comprising a genetic syndrome. Autosomal dominant variants in TAB2 are recognized by the American Heart Association as causing nonsyndromic CHD, however, emerging data point to additional, extra-cardiac features associated with TAB2 variants. We identified 15 newly reported individuals with pathogenic TAB2 variants and reviewed an additional 24 subjects with TAB2 variants in the literature. Analysis showed 64% (25/39) of individuals with disease resulting from TAB2 single nucleotide variants (SNV) had syndromic CHD or adult-onset cardiomyopathy with one or more extra-cardiac features. The most commonly co-occurring features with CHD or cardiomyopathy were facial dysmorphism, skeletal and connective tissue defects and most subjects with TAB2 variants present as a connective tissue disorder. Notably, 53% (8/15) of our cohort displayed developmental delay and we suspect this may be a previously unappreciated feature of TAB2 disease. We describe the largest cohort of subjects with TAB2 SNV and show that in addition to heart disease, features across multiple systems are present in most TAB2 cases. In light of our findings, we recommend that TAB2 be included on the list of genes that cause syndromic CHD, adult-onset cardiomyopathy, and connective tissue disorder.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Doenças do Tecido Conjuntivo / Proteínas Adaptadoras de Transdução de Sinal / Transtornos do Neurodesenvolvimento / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Clin Genet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Doenças do Tecido Conjuntivo / Proteínas Adaptadoras de Transdução de Sinal / Transtornos do Neurodesenvolvimento / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Clin Genet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos